Robert A. DeSutter - 09 Feb 2022 Form 4 Insider Report for Sanara MedTech Inc. (SMTI)

Reporting relationship: Director
Issuer ticker: SMTI
Reported as of: 09 Feb 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Feb 2022, 16:25:11 UTC
Next SEC filing: 08 Jul 2022
Source filing: View source filing
Reporting owner signature: /s/ Robert A. DeSutter

Key filing fact

Robert A. DeSutter filed Form 4 for Sanara MedTech Inc. (SMTI) on 11 Feb 2022.

Key facts

This page summarizes Robert A. DeSutter's Form 4 filing for Sanara MedTech Inc. (SMTI).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 11 Feb 2022, 16:25.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SMTI transaction

Common Stock

Award

Transaction value: $0
Shares: +4,887
Change %
Price: $0.000000
Shares after: 4,887
Date: 09 Feb 2022
Ownership: Direct
Footnotes: F1

SMTI transaction

Common Stock

Award

Transaction value: $0
Shares: +2,444
Change %: +50%
Price: $0.000000
Shares after: 7,331
Date: 09 Feb 2022
Ownership: Direct
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. All of the shares of restricted stock vested on February 9, 2022.

Footnote F2

Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on the date of the Company's 2022 annual meeting of shareholders; provided that the reporting person is providing services to the Company until such date.